RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia.

about

A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells.Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients.

P2860

Q47284616-3A433180-49A1-4740-8C47-E4566194CDED Q55341003-DEDB86E5-F784-4F18-9AB6-AAD9202ACB38

P2860

RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q45065002

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

RUNX1 is required for oncogeni ...... acute lymphoblastic leukemia.

@en

RUNX1 is required for oncogeni ...... acute lymphoblastic leukemia.

@nl

type

Item

label

RUNX1 is required for oncogeni ...... acute lymphoblastic leukemia.

@en

RUNX1 is required for oncogeni ...... acute lymphoblastic leukemia.

@nl

prefLabel

RUNX1 is required for oncogeni ...... acute lymphoblastic leukemia.

@en

RUNX1 is required for oncogeni ...... acute lymphoblastic leukemia.

@nl

P1476

RUNX1 is required for oncogeni ...... acute lymphoblastic leukemia.

@en

P2093

AHyun Choi

http://www.w3.org/2001/XMLSchema#string

Anuradha Illendula

http://www.w3.org/2001/XMLSchema#string

Jessica Tesell

http://www.w3.org/2001/XMLSchema#string

John A Pulikkan

http://www.w3.org/2001/XMLSchema#string

Jun Yu

http://www.w3.org/2001/XMLSchema#string

Justine E Roderick

http://www.w3.org/2001/XMLSchema#string

Lihua Julie Zhu

http://www.w3.org/2001/XMLSchema#string

Lucio H Castilla

http://www.w3.org/2001/XMLSchema#string

Nicole Hermance

http://www.w3.org/2001/XMLSchema#string

P2860

Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia

Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt

The RUNX genes: gain or loss of function in cancer

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

Super-enhancers in the control of cell identity and disease

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers

P304

1722-1733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-03-775536

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

John H Bushweller

Michelle Kelliher

P577

2017-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28790107

http://www.w3.org/2001/XMLSchema#string

P932

5639483

http://www.w3.org/2001/XMLSchema#string

RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia.

about

P2860

P2860

RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932